Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
$2.09
-12.9%
$3.33
$1.84
▼
$10.25
$132.68MN/A823,937 shs1.25 million shs
eGain Corporation stock logo
EGAN
eGain
$5.59
-3.6%
$5.73
$5.02
▼
$11.52
$155.87M0.82170,351 shs203,239 shs
BitFuFu Inc. stock logo
FUFU
BitFuFu
$0.88
+2.3%
$1.17
$0.64
▼
$3.47
$141.62M0.47278,869 shs942,245 shs
GRDX
Entero Therapeutics
$3.25
-5.9%
$4.29
$1.87
▼
$6.93
$23.53M1.67141,917 shs125,150 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
-12.44%-21.43%-37.05%-66.51%+208,999,900.00%
eGain Corporation stock logo
EGAN
eGain
-3.62%-9.84%-1.41%-23.42%-46.71%
BitFuFu Inc. stock logo
FUFU
BitFuFu
+2.33%+6.85%-16.98%-44.30%-69.55%
GRDX
Entero Therapeutics
-5.94%-13.24%-33.78%-9.10%+324,499,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
$2.09
-12.9%
$3.33
$1.84
▼
$10.25
$132.68MN/A823,937 shs1.25 million shs
eGain Corporation stock logo
EGAN
eGain
$5.59
-3.6%
$5.73
$5.02
▼
$11.52
$155.87M0.82170,351 shs203,239 shs
BitFuFu Inc. stock logo
FUFU
BitFuFu
$0.88
+2.3%
$1.17
$0.64
▼
$3.47
$141.62M0.47278,869 shs942,245 shs
GRDX
Entero Therapeutics
$3.25
-5.9%
$4.29
$1.87
▼
$6.93
$23.53M1.67141,917 shs125,150 shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
-12.44%-21.43%-37.05%-66.51%+208,999,900.00%
eGain Corporation stock logo
EGAN
eGain
-3.62%-9.84%-1.41%-23.42%-46.71%
BitFuFu Inc. stock logo
FUFU
BitFuFu
+2.33%+6.85%-16.98%-44.30%-69.55%
GRDX
Entero Therapeutics
-5.94%-13.24%-33.78%-9.10%+324,499,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
1.00
SellN/AN/A
eGain Corporation stock logo
EGAN
eGain
2.00
Hold$6.5016.28% Upside
BitFuFu Inc. stock logo
FUFU
BitFuFu
2.50
Moderate Buy$4.00354.55% Upside
GRDX
Entero Therapeutics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest GRDX, EGAN, AIBZ, and FUFU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/20/2026
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
DowngradeSell (D-) ➝ Sell (E+)
11/4/2026
eGain Corporation stock logo
EGAN
eGain
Reiterated RatingHold (C)
10/6/2026
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
Initiated CoverageSell (D-)
9/27/2026
BitFuFu Inc. stock logo
FUFU
BitFuFu
UpgradeStrong-Buy
9/16/2026
BitFuFu Inc. stock logo
FUFU
BitFuFu
DowngradeSell (D) ➝ Sell (D-)
9/8/2026
eGain Corporation stock logo
EGAN
eGain
Reiterated RatingNeutral
9/8/2026
eGain Corporation stock logo
EGAN
eGain
DowngradeBuy ➝ Neutral$21.00 ➝ $7.00
9/8/2026
eGain Corporation stock logo
EGAN
eGain
Lower Price TargetNeutral$10.50 ➝ $6.00
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
$7.50M15.09N/AN/AN/A∞
eGain Corporation stock logo
EGAN
eGain
$91.14M1.55$0.43 per share13.08$3.28 per share1.70
BitFuFu Inc. stock logo
FUFU
BitFuFu
$475.77M0.31$0.12 per share7.37$0.90 per share0.98
GRDX
Entero Therapeutics
$40K578.42N/AN/A$7.42 per share0.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
-$12.09M-$0.24N/AN/AN/AN/A-167.23%-56.70%N/A
eGain Corporation stock logo
EGAN
eGain
$8.88M$0.2819.96N/AN/A8.50%8.76%5.31%2/2/2027 (Estimated)
BitFuFu Inc. stock logo
FUFU
BitFuFu
-$31.25M-$0.84N/AN/AN/A-36.00%-18.05%-7.46%N/A
GRDX
Entero Therapeutics
-$6.39M-$1.90N/AN/AN/AN/A-47.34%-16.07%N/A

Latest GRDX, EGAN, AIBZ, and FUFU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/20/2026Q3 2026
BitFuFu Inc. stock logo
FUFU
BitFuFu
$0.03$0.14+$0.11$0.14$42.70 million$37.73 million
11/16/2026Q3 2026
GRDX
Entero Therapeutics
N/A-$0.27N/A-$0.27N/A$0.04 million
11/5/2026Q1 2027
eGain Corporation stock logo
EGAN
eGain
$0.06$0.09+$0.03$0.06$21.11 million$21.87 million
9/3/2026Q4 2026
eGain Corporation stock logo
EGAN
eGain
$0.03$0.08+$0.05$0.05$21.75 million$22.15 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
N/AN/AN/AN/AN/A
eGain Corporation stock logo
EGAN
eGain
N/AN/AN/AN/AN/A
BitFuFu Inc. stock logo
FUFU
BitFuFu
N/AN/AN/AN/AN/A
GRDX
Entero Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
1.15
0.35
0.35
eGain Corporation stock logo
EGAN
eGain
N/A
1.83
1.73
BitFuFu Inc. stock logo
FUFU
BitFuFu
1.03
4.22
4.22
GRDX
Entero Therapeutics
N/A
0.16
0.16

Institutional Ownership

CompanyInstitutional Ownership
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
N/A
eGain Corporation stock logo
EGAN
eGain
53.94%
BitFuFu Inc. stock logo
FUFU
BitFuFu
37.26%
GRDX
Entero Therapeutics
12.30%

Insider Ownership

CompanyInsider Ownership
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
N/A
eGain Corporation stock logo
EGAN
eGain
41.10%
BitFuFu Inc. stock logo
FUFU
BitFuFu
35.00%
GRDX
Entero Therapeutics
0.75%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bitzero Holdings Inc. stock logo
AIBZ
Bitzero
854.15 millionN/AOptionable
eGain Corporation stock logo
EGAN
eGain
42225.22 million14.86 millionOptionable
BitFuFu Inc. stock logo
FUFU
BitFuFu
29166.61 million108.30 millionN/A
GRDX
Entero Therapeutics
27.13 million8.48 millionN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bitzero stock logo

Bitzero NASDAQ:AIBZ

$2.09 -0.31 (-12.92%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$2.09 0.00 (0.00%)
As of 11/20/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bitzero Holdings Inc. is a provider of IT energy infrastructure and power for data centers. It provides Bitcoin mining, as well as hosts and provides space and operating and maintenance services to third-party mining companies. The company has four data centers in the North American and Scandinavian regions. Bitzero Holdings Inc. is based in Vancouver, Canada.

eGain stock logo

eGain NASDAQ:EGAN

$5.59 -0.21 (-3.62%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$5.62 +0.04 (+0.63%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

eGain Corporation develops, licenses, implements, and supports customer service infrastructure software solutions in North America, Europe, the Middle East, Africa, and the Asia Pacific. It provides eGain Knowledge Hub, which helps businesses to centralize knowledge, policies, procedures, situational expertise, best-practices, while delivering guided, and personalized solutions to customers and agents; eGain Conversation Hub for digital-first, omnichannel interaction management within a modern, purpose-built desktop; and eGain Analytics Hub enables clients to measure, manage, and optimize omnichannel service operations and knowledge. The company also offers subscription services that provides customers with access to its software on a cloud-based platform; and professional services, such as consulting and implementation, training, and managed services. It serves customers in various industry sectors, including the financial services, telecommunications, retail, government, healthcare, and utilities. The company was incorporated in 1997 and is headquartered in Sunnyvale, California.

BitFuFu stock logo

BitFuFu NASDAQ:FUFU

$0.88 +0.02 (+2.33%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$0.90 +0.02 (+2.05%)
As of 11/20/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BitFuFu Inc. provides digital asset mining and cloud-mining services in Singapore. It also offers miner rental, and miner hosting and sales services to institutional customers and individual digital asset enthusiasts. The company is based in Singapore, Singapore.

Entero Therapeutics NASDAQ:GRDX

$3.24 -0.21 (-5.94%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$3.26 +0.01 (+0.46%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies; and capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis. It is also involved in the development of adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, currently under Phase 2 studies for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis; and niclosamide, an oral small molecule with anti-inflammatory inhibitor therapy, currently under Phase 2 studies for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, as well as immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.